Clotilde Descarpentries

Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients

Clotilde Descarpentries, Frédéric Leprêtre, Fabienne Escande et al. · Journal of Thoracic Oncology · 2018 · 42 citations · Full text

Somatic Variant, Mendelian Disorder, Genetic Disorder +9

Is Modification of Diet in Renal Disease Formula Similar to Cockcroft-Gault Formula to Assess Renal Function in Elderly Hospitalized Patients Treated With Low-Molecular-Weight Heparin?

Isabelle Gouin‐Thibault, Éric Pautas, Isabelle Mahé et al. · The Journals of Gerontology Series A · 2007 · 30 citations · Full text

Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer

Elisabeth Dequeker, Cleo Keppens, C. Egelé et al. · Journal of Molecular Diagnostics · 2016 · 30 citations

External Quality Assessment, Cancer Detection, Cancer Screening +12

High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study

Simon Baldacci, Martin Figeac, Martine Antoine et al. · Journal of Thoracic Oncology · 2019 · 27 citations · Full text

Medicine, Genetics, Molecular Biology +4

<scp>MET</scp> exon 14 skipping mutation is a hepatocyte growth factor (<scp>HGF</scp>)‐dependent oncogenic driver <i>in vitro</i> and in humanised <i>HGF</i> knock‐in mice

Marie Fernandes, Brynna Hoggard, Philippe Jamme et al. · Molecular Oncology · 2023 · 25 citations · Full text

Engineering, Human Growth, Genetics +21